redefining-care_one-color
redefining-care_one-color

 

Through purpose-driven science, empowering medicines, and transformative advocacy we seek to improve the lives of millions.

Learn more »

Our areas of focus

Uterine Fibroids

An estimated 19 million women in the U.S. have uterine fibroids.

Learn more »

Endometriosis

An estimated 7.5 million premenopausal women in the U.S. have endometriosis.

Learn more »

Prostate Cancer

Approximately 3 million men alive today in the U.S. have been diagnosed with prostate cancer.

Learn more »

MYOVANT STORIES

Overcoming Stigma with Care and Community

Thomasine’s journey through uterine fibroids started with pain but led to empowerment.

Read Thomasine’s story

PURPOSE-DRIVEN SCIENCE

Myovant is developing innovative medicines that hold promise to improve people’s lives.

View our pipeline

TRANSFORMATIVE ADVOCACY

We’re partnering with cross-sector coalitions to fight stigma, raise awareness, and empower people with information.

Learn more

STATEMENT

30 Jun 2022
Myovant Statement: U.S. Supreme Court Ruling in Dobbs v. Jackson Women’s Health Organization

You are leaving www.myovant.com, a website provided by Myovant Sciences GmbH.
This link will take you to a different site.